CLDX : Summary for Celldex Therapeutics, Inc. - Yahoo Finance

U.S. Markets close in 1 hr 30 mins

Celldex Therapeutics, Inc. (CLDX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.35-0.01 (-0.22%)
As of 2:28PM EDT. Market open.
People also watch
ACADARRYCLVSSRPTSGEN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.36
Open3.35
Bid3.34 x 2900
Ask3.35 x 1200
Day's Range3.29 - 3.39
52 Week Range2.85 - 5.13
Volume945,112
Avg. Volume1,911,454
Market Cap413.07M
Beta3.03
PE Ratio (TTM)-2.65
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube23 hours ago

    ETFs with exposure to Celldex Therapeutics, Inc. : March 27, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Celldex Therapeutics, Inc. Here are 5 ETFs with the largest exposure to CLDX-US. Comparing the performance and risk of Celldex Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • 3 Stocks That Could Double Your Money
    Motley Fool3 days ago

    3 Stocks That Could Double Your Money

    Wall Street has great expectations for biotech stocks Celldex Therapeutics, Idera Pharmaceuticals, and Opko Health.

  • Celldex Therapeutics, Inc. :CLDX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
    Capital Cube7 days ago

    Celldex Therapeutics, Inc. :CLDX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017

    Categories: Yahoo Finance Get free summary analysis Celldex Therapeutics, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Celldex Therapeutics, Inc. – Seattle Genetics, Inc., Emergent BioSolutions Inc., Agenus Inc., GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Vical Incorporated, Bristol-Myers Squibb Company, Pfizer Inc. and CytRx Corporation ... Read more (Read more...)